BEAM
Price
$22.24
Change
-$0.29 (-1.29%)
Updated
May 8, 6:59 PM EST
89 days until earnings call
SNDX
Price
$22.38
Change
-$0.80 (-3.45%)
Updated
May 8, 6:59 PM EST
Earnings call today
Ad is loading...

BEAM vs SNDX

Header iconBEAM vs SNDX Comparison
Open Charts BEAM vs SNDXBanner chart's image
Beam Therapeutics
Price$22.24
Change-$0.29 (-1.29%)
Volume$468.64K
CapitalizationN/A
Syndax Pharmaceuticals
Price$22.38
Change-$0.80 (-3.45%)
Volume$671.27K
CapitalizationN/A
View a ticker or compare two or three
BEAM vs SNDX Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNDXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. SNDX commentary
May 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and SNDX is a Sell.

COMPARISON
Comparison
May 09, 2024
Stock price -- (BEAM: $22.24 vs. SNDX: $22.38)
Brand notoriety: BEAM and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 62% vs. SNDX: 103%
Market capitalization -- BEAM: $1.83B vs. SNDX: $1.9B
BEAM [@Biotechnology] is valued at $1.83B. SNDX’s [@Biotechnology] market capitalization is $1.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $567.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileSNDX’s FA Score has 2 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • SNDX’s FA Score: 2 green, 3 red.
According to our system of comparison, SNDX is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while SNDX’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 3 bearish.
  • SNDX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than SNDX.

Price Growth

BEAM (@Biotechnology) experienced а +2.30% price change this week, while SNDX (@Biotechnology) price change was +1.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.31%. For the same industry, the average monthly price growth was -4.54%, and the average quarterly price growth was +71.32%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 06, 2024.

SNDX is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Biotechnology (+1.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for SNDX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SNDX($1.97B) has a higher market cap than BEAM($1.83B). SNDX YTD gains are higher at: 7.265 vs. BEAM (-18.295).
BEAMSNDXBEAM / SNDX
Capitalization1.83B1.97B93%
EBITDAN/AN/A-
Gain YTD-18.2957.265-252%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
31
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMSNDX
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 14 days ago
79%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNDXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTDZX143.140.58
+0.41%
Franklin Biotechnology Discovery Adv
MAAKX23.100.05
+0.22%
MoA All America Fund
MLUAX12.180.02
+0.16%
MassMutual Mid Cap Value A
DFQTX35.020.04
+0.11%
DFA US Core Equity 2 I
CEARX12.56-0.03
-0.24%
Columbia Acorn Adv

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with NTLA. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-1.29%
NTLA - BEAM
77%
Closely correlated
-3.69%
DNLI - BEAM
68%
Closely correlated
+12.17%
PRME - BEAM
62%
Loosely correlated
-3.77%
EDIT - BEAM
62%
Loosely correlated
-11.36%
VERV - BEAM
61%
Loosely correlated
-1.30%
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with NTLA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
+3.02%
NTLA - SNDX
46%
Loosely correlated
+0.67%
RAPT - SNDX
45%
Loosely correlated
-2.42%
VCYT - SNDX
45%
Loosely correlated
+0.53%
NRIX - SNDX
44%
Loosely correlated
+7.11%
BEAM - SNDX
43%
Loosely correlated
-1.10%
More